Oxford Global, London
13th-15th March 2024
Oxford Global is excited to announce that our 3rd Annual Oligonucleotides Congress will be returning to London on the 13th to 15th March 2024. Registration is now open so don’t hesitate to join us for our revamped and expanded agendas, bringing together over 500 leading experts in biologics drug discovery and therapeutic development – will you be among them? The Oligonucleotides Congress includes... - Over 500 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions
- Hear from key opinion leaders in oligonucleotide CMS & analytical development. Presentations will be covering computational approaches, methods & tools as well as analytical control strategies for oligos
- Discuss the latest therapeutic development success stories with thought-leaders presenting on immunogenicity considerations, progress to clinical trials and RNA targeting
- Over 20 presentations, case-studies, workshops, panel discussions, and roundtables focusing on developing sustainable manufacturing processes, technologies for the oral delivery of oligonucleotides, advancing computational approaches for oligo optimisation, and emerging therapeutic applications of antisense oligonucleotides
- Our brand-new Biologics Innovation & Collaboration Track featuring pioneering presentations from emerging biotechs and spin-off companies.
Co-located with our 17th Annual Proteins & Antibodies, 11th Annual Peptides Congress and 2nd Annual Sustainability In Biologics Congresses, there will be over 100 thought-provoking presentations taking place on-site for you to explore, alongside a plethora of networking opportunities and interactive sessions.
|
|
|
Invited Speakers:
|
|
Our commitment to providing you with the most valuable and up-to-date information remains steadfast, and we are thrilled to unveil a line-up of keynote speakers who are at the forefront of Oligonucleotide innovation. These thought leaders and industry pioneers will be sharing their expertise, new case studies, and the latest data insights to shape the industry's future at the 3rd Annual Oligonucleotides Congress. View the full line up here >>
|
|